Talk:Tissue engineering
From Wikipedia, the free encyclopedia
I also agree, added a reference and pointed to the lab doing tissue engineering without a scaffold - www.case.edu/med/dotel and had it deleted twice should this go in? —Preceding unsigned comment added by Keantom (talk • contribs) 20:48, 23 April 2008 (UTC)
I agree, tissue engineering isnt just about cell seeded scaffolds. Also, the development from cells plus scaffold/proteins is complex and dependent on a lot of factors, most of which are not mentioned. There needs to be some semblance of a section on the conditioning, i.e. the feeding, stretching, shaping, the chemical environment, the temperature, the timing. I intend to work on this at some point. --Sam
I added the reference to Langer and vacanti Science 1993 and a snippet in the text about the definition. --Bedrupsbaneman
Some sections on this page copied from other literature of which I am the copyright holder - regards, Vincent Murphy
Tissue engineering isn't just about cell seeded scaffolds. There are other routes being investigated to achieve the formation of neo-organs which do not involve the use of engineering materials. - SB
Neither of the two definitions of TE state that TE (must) involve synthetic materials. Bedrupsbaneman 28 June 2005 15:28 (UTC)
[edit] Agencies that Support Tissue Engineering Research
Question: 'Agencies that Support Tissue Engineering Research'
These both appear to be US agencies and it is against wikipedia policy to have a US bias on global articles. Suggest this is either expanded to cover funding sources in all more countries or removed? soflution 10:32, 2 February 2006 (UTC)
- Did a quick internet search: according to this old article [1] ESA should be interested in TE and possibly also the European Medicines Agency (EMEA) could be interested. Maybe a more thorough search could confirm this. Berserker79 11:13, 2 February 2006 (UTC)
- Are there any (biomedical) national research agencies that oppose tissue engineering? Making a complete list of agencies that support TE would soon be very exhaustive. From a reseach and business policy point of view it is of course of global interest what actions NSF and NIH (and of course FDA) are taking since the US is the largest market both for both research and clinical applications. Maybe make a separate article to monitor research policies regarding TE?